Edition:
United Kingdom

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

3.36USD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$3.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
64,849
52-wk High
$5.82
52-wk Low
$1.59

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.19 December 15 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.33 1.33 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2 5.12 5.17 5.07 3.10
Quarter Ending Dec-18 2 7.58 8.40 6.76 3.30
Year Ending Dec-18 2 21.77 22.54 21.00 12.25
Year Ending Dec-19 3 28.97 31.80 24.13 --
Earnings (per share)
Quarter Ending Sep-18 2 -0.19 -0.18 -0.19 -0.43
Quarter Ending Dec-18 2 -0.17 -0.10 -0.24 -0.43
Year Ending Dec-18 2 -0.71 -0.63 -0.79 -1.73
Year Ending Dec-19 3 -0.59 -0.48 -0.71 20.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 5.29 4.91 0.38 7.09
Quarter Ending Mar-18 4.97 4.16 0.81 16.35
Quarter Ending Dec-17 6.97 7.90 0.93 13.32
Quarter Ending Sep-17 2.90 3.72 0.82 28.40
Quarter Ending Jun-17 1.70 1.76 0.06 3.53

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5.12 5.16 5.16 5.24 3.10
Quarter Ending Dec-18 7.58 7.73 7.73 8.31 3.30
Year Ending Dec-18 21.77 22.34 22.34 23.00 12.25
Year Ending Dec-19 28.97 28.99 28.99 31.42 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 1 1 1 1
Quarter Ending Dec-18 1 1 1 1
Year Ending Dec-18 0 2 0 2
Year Ending Dec-19 1 1 1 1
Earnings